TradingView
warrenhochfeld
Nov 20, 2017 7:43 PM

Second Axsome AXSM buy opportunity Long

Axsome Therapeutics, Inc.NASDAQ

Description

Current share price is testing the upward trending lower resistance line. As the lower resistance line crosses the $5 inflection line we could expect major movement ahead of the Q42017/Q12018 FDA catalysts.
More